Mycotopia Therapies, Inc.
TPIA · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $61 | $1 | $0 |
| Gross Profit | $0 | -$61 | -$1 | -$0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1,635 | $617 | $1,876 | $2,669 |
| SG&A Expenses | $1,635 | $556 | $1,876 | $2,669 |
| Sales & Mktg Exp. | $0 | -$61 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1,635 | $556 | $1,876 | $2,669 |
| Operating Income | -$1,635 | -$617 | -$1,876 | -$2,669 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$213 | -$565 | -$876 | -$152 |
| Pre-Tax Income | -$1,848 | -$1,181 | -$2,751 | -$2,821 |
| Tax Expense | $0 | $0 | $876 | $152 |
| Net Income | -$1,848 | -$1,181 | -$3,627 | -$2,972 |
| % Margin | – | – | – | – |
| EPS | -0.14 | -0 | -0.25 | -0.22 |
| % Growth | -139,900% | 100% | -13.6% | – |
| EPS Diluted | -0.14 | -0 | -0.25 | -0.22 |
| Weighted Avg Shares Out | 13,384 | 14,884 | 14,445 | 13,413 |
| Weighted Avg Shares Out Dil | 13,384 | 14,884 | 14,445 | 13,413 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $1 | $0 |
| Interest Expense | -$213 | $0 | $876 | $152 |
| Depreciation & Amortization | $0 | $61 | $1 | $0 |
| EBITDA | -$1,635 | -$556 | -$1,735 | -$4,987 |
| % Margin | – | – | – | – |